Session Synopsis: Value-based care models in complex diseases like cancer hold the most promise for being able to increase patient outcomes and lower the overall total cost of care. This session will explain how the secret to enabling the creation of successful value-based models is a precision data approach using Electronic Health Record data, with examples from a pilot between one of the country’s largest cancer centers and a large payer.
Session Chair Profile
M.D., Chief Medical Officer, Cota Healthcare Inc.
Stuart Goldberg MD is Chief Medical Officer at Cota, Inc. and Associate Clinical Professor of Medicine at Rutgers at the New Jersey Medical School. He also maintains an active clinical practice in the Division of Leukemia at the John Theurer Cancer Center. Dr. Goldberg obtained his medical degree at the Pennsylvania State University and fellowships in hematology-oncology and bone marrow transplantation at George Washington University Medical Center and Mayo Clinic. In the field of “big data” analysis he has used Medicare and MarketScan databases to redefine the incidence and complications related with myelodysplastic syndromes (published in JCO and Transfusion) and has reviewed observational databases (including SIMPLICITY) to foster adherence with evidence-based CML monitoring guidelines (published in JOP, CRMO and CLML). Most recently, he has used the Cota database to explore rates and implications of EGFR mutational testing among community oncologists and cost-effectiveness of genomic profiling in lower-risk breast cancer.
M.D., FAAFP, Vice President and Chief Medical Officer, Horizon Blue Cross
Dr. Graf brings 25 years of experience in advancing healthcare delivery, reducing cost of care, and supporting continuous growth and performance improvement. Dr. Graf applies his deep understanding of economic, social, and regulatory issues with his clinical experience to align diverse stakeholders and build consensus around shared strategic and operational goals, bridging the unique perspectives provided by physicians, hospitals, payors, patients, and employers. He adeptly translates overarching strategies into targeted operational and performance improvement efforts to help organizations navigate through the evolving and turbulent landscape. Prior to joining Horizon, he was National Director for Population Health for The Chartis Group helping dozens of provider systems and groups to create strategy and improve performance in driving quality to lower total cost of care and comprehensively care for populations. Prior to Chartis Dr Graf served for nearly twelves years in various roles at Geisinger. In his final position there, Dr. Graf was the Chief Medical Officer for Population Health and Longitudinal Care Service Lines. There, he was responsible for the value re- engineering of the care continuum and other population health initiatives for Geisinger including the ACO portfolio, the Physician Group Practice, and PGP Transitions Demonstrations and Bundled Payments for Care Improvement. Operationally he had responsibility for the community practice, internal medicine, medical specialties, pediatrics, psychiatry, oncology, neurosciences, women’s health, and care continuum service lines across 22 counties in central and northeast Pennsylvania. After graduating from University of Michigan Medical School and completing family medicine residency training at Henry Ford Health System in Detroit, Dr. Graf served on the faculty of the Henry Ford Family Practice Residency and was Director of the Southwest Georgia Family Practice Residency.